Ensuring meaningful support for immigrants living with HIV requires more than healthcare access, demanding comprehensive ...

Since breaking the ceasefire, Israeli forces have declared about 70 percent of Gaza either as a military “red zone” or under ...

Israel asks Greece, Cyprus, Italy and Croatia for help as at least five separate fires raged in the Jerusalem hills.

Netanyahu declares national emergency as record blaze nears Jerusalem - Fire is being whipped up by strong winds and hot, dry ...

Nikos Pekiaridis / NurPhoto via Getty Images Gilead Sciences missed first-quarter revenue estimates as sales of its COVID-19 and cancer drugs declined. The biopharma's profit got a lift from ...

For the period, Gilead's revenue clocked in at $6.67 billion, essentially flat over the same quarter of 2024. The company attributed this to sales declines of COVID drug Veklury and oncology products.

Gilead's HIV franchise remains dominant, generating $19.612 billion in 2024, but faces potential funding challenges impacting future growth. Efforts to build a cancer franchise have been mixed ...

Gilead and Roche are continuing to lay off employees in California, with each company revealing a recent round of cuts through the state’s Worker Adjustment and Retraining Notification (WARN ...

Good afternoon, everyone, and welcome to Gilead's First Quarter 2025 Earnings Conference Call. My name is Rebecca, and I'll be today's host. In a moment, we'll begin our prepared remarks ...

The first-ever interactive digital map detailing Hamas’s tunnel network in Gaza was published by Honest Reporting earlier this week, according to a Friday post on X/Twitter by the organization.

Gilead Sciences (GILD) ended the recent trading session at $111.88, demonstrating a +0.54% swing from the preceding day's closing price. The stock fell short of the S&P 500, which registered a ...